Cross-fund · 4 holders
TVTX
TRAVERE THERAPEUTICS INC
CUSIP 89422G107
4
Tracked holders
$487.5M
Aggregate value
14,601,926
Shares
5
Active funds
Funds holding TVTX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $241.1M | — | −304,139 | −4.6% |
| BlackRock | Institutional | Q1 2026 | $231.5M | — | −77,319 | −1.0% |
| Citadel | Multi-Strategy | Q1 2026 | $14.3M | — | +177,929 | +58.8% |
| Millennium | Multi-Strategy | Q1 2026 | $594,200 | — | −226,065 | −91.9% |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | −1,203,783 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.